company background image
600833 logo

Shanghai No.1 PharmacyLtd SHSE:600833 Stock Report

Last Price

CN¥11.19

Market Cap

CN¥2.5b

7D

-0.09%

1Y

-10.5%

Updated

26 Apr, 2024

Data

Company Financials

Shanghai No.1 Pharmacy Co.,Ltd.

SHSE:600833 Stock Report

Market Cap: CN¥2.5b

600833 Stock Overview

Shanghai No.1 Pharmacy Co., Ltd. engages in the retail and wholesale of pharmaceutical products.

600833 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance1/6
Financial Health5/6
Dividends4/6

Shanghai No.1 Pharmacy Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shanghai No.1 PharmacyLtd
Historical stock prices
Current Share PriceCN¥11.19
52 Week HighCN¥14.91
52 Week LowCN¥7.91
Beta0.56
1 Month Change10.36%
3 Month Change-5.25%
1 Year Change-10.48%
3 Year Change23.10%
5 Year Change7.29%
Change since IPO171.87%

Recent News & Updates

Shanghai No.1 PharmacyLtd's (SHSE:600833) Shareholders Have More To Worry About Than Only Soft Earnings

Apr 09
Shanghai No.1 PharmacyLtd's (SHSE:600833) Shareholders Have More To Worry About Than Only Soft Earnings

Recent updates

Shanghai No.1 PharmacyLtd's (SHSE:600833) Shareholders Have More To Worry About Than Only Soft Earnings

Apr 09
Shanghai No.1 PharmacyLtd's (SHSE:600833) Shareholders Have More To Worry About Than Only Soft Earnings

Shareholder Returns

600833CN Consumer RetailingCN Market
7D-0.09%2.0%2.1%
1Y-10.5%-20.2%-14.2%

Return vs Industry: 600833 exceeded the CN Consumer Retailing industry which returned -21.2% over the past year.

Return vs Market: 600833 exceeded the CN Market which returned -14.6% over the past year.

Price Volatility

Is 600833's price volatile compared to industry and market?
600833 volatility
600833 Average Weekly Movement7.2%
Consumer Retailing Industry Average Movement7.4%
Market Average Movement8.7%
10% most volatile stocks in CN Market12.7%
10% least volatile stocks in CN Market5.2%

Stable Share Price: 600833's share price has been volatile over the past 3 months.

Volatility Over Time: 600833's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a870Jun Yaowww.shdyyy.com.cn

Shanghai No.1 Pharmacy Co., Ltd. engages in the retail and wholesale of pharmaceutical products. The company offers products in the categories of Chinese and Western medicines, nutrition and health products, medical equipment, Chinese herbal medicines, etc. In addition, it provides consulting and guidance on safe medication, rational medication, and chronic disease medication. Shanghai No. 1 Pharmacy Co., Ltd.

Shanghai No.1 Pharmacy Co.,Ltd. Fundamentals Summary

How do Shanghai No.1 PharmacyLtd's earnings and revenue compare to its market cap?
600833 fundamental statistics
Market capCN¥2.50b
Earnings (TTM)CN¥89.28m
Revenue (TTM)CN¥1.82b

28.0x

P/E Ratio

1.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600833 income statement (TTM)
RevenueCN¥1.82b
Cost of RevenueCN¥1.47b
Gross ProfitCN¥345.21m
Other ExpensesCN¥255.94m
EarningsCN¥89.28m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 30, 2024

Earnings per share (EPS)0.40
Gross Margin18.97%
Net Profit Margin4.91%
Debt/Equity Ratio9.5%

How did 600833 perform over the long term?

See historical performance and comparison

Dividends

1.1%

Current Dividend Yield

31%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.